期刊文献+

唑来膦酸对破骨细胞分化中钙调蛋白、钙调磷酸酶表达的影响 被引量:7

The effect of zoledronate on gene expression of calmodulin and calcineurin during osteoclast differentiation
下载PDF
导出
摘要 目的 :探讨唑来膦酸(zoledronate,ZOL)对破骨细胞分化中钙调蛋白(calmodulin)和钙调磷酸酶(calcineurin)基因表达的影响。方法:小鼠RAW264.7细胞分为A、B两组,均用100 ng/m L核因子κB受体激活蛋白配体(RANKL)诱导4 d;B组细胞在RANKL诱导第2天加入1×10-6mol/L ZOL处理48 h。RANKL诱导4 d后收获细胞,检测破骨细胞生成及calmodulin、calcineurin基因表达情况。结果 :B组多核破骨细胞数、吸收陷窝数目及面积分别为(8.8±2.3)个、(6.7±1.2)个和(997.1±14.8)μm^2,均显著低于A组的(19.7±2.9)个、(13.3±1.5)个和(1 676.9±24.9)μm^2(P<0.01)。B组calmodulin mRNA及蛋白水平较A组分别降低了51.0%和78.7%(P<0.05),calcineurin则分别下降了37.0%和69.5%(P<0.01)。免疫荧光细胞化学显示,B组calmodulin、calcineurin的荧光强度较A组也明显下降。结论:ZOL可显著抑制破骨细胞生成,并下调破骨细胞分化中calmodulin和calcineurin的m RNA和蛋白水平,而calmodulin、calcineurin可能参与了ZOL对破骨细胞形成和功能的抑制。 Objective:The study is aimed to examine the effects of zoledronate(ZOL) on gene expression of calmodulin and calcineurin during differentiation of osteoclasts. Methods:RAW264.7 cells were divided into 2 groups,group A and group B. The cells in both groups were induced with 100 ng / ml RANKL(ligand of receptor activator of nuclear factor κB)for 4 d for osteoclast differentiation. At the second day of RANKL induction,cells in group B also treated with 1×10^(-6)mol / L ZOL for 48 h. Four days later,the cells were harvested and examined for osteoclastogenesis,as well as gene expression of both calmodulin and calcineurin. Results: TRAP positive multinuclear cells,number and size of resorption lacunaes in group B were 8.8 ± 2.3,6.7 ± 1.2 and 997.1 ± 14.8 μm^2 respevtively,which were significantly lower than those(19.7 ± 2.9,13.3 ± 1.5 and 1676.9 ± 24.9 μm^2)in group A(P〈0.01). mRNA and protein level of calmodulin in group B decreased about 51% and 78.7%,respectively when compared with group A(P〈0.05),and those of calcineurin also decreased about 37% and 69.5%,respectively(P〈0.05). Immunofluorescent cytochemistry showed obvious decrease of fluorescent intensity of calmodulin and calcineurin protein in group B when compared with group A. Conclusion:ZOL significantly inhibits osteoclastogenesis and down-regulates gene expression of calmodulin and calcineurin,which may play a role in ZOL-induced inhibition of osteoclastogenesis.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2016年第2期171-175,217,共6页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金(81270965)
关键词 唑来膦酸 破骨细胞 钙调蛋白 钙调磷酸酶 基因调控 zoledronate osteoclast calmodulin calcineurin gene regulation
  • 相关文献

参考文献19

  • 1Edwards JR,Weivoda MM. Osteoclasts:malefactors of dis- ease and targets for treatment [J]. Discov Med,2012, 13 (70):201-210.
  • 2Negishi-Koga T,Takayanagi H. Ca-(2+)-NFATcl sig- naling is an essential axis of osteoclast differentiation[J]. Immunol Rev, 2009,231 ( 1 ) : 241-256.
  • 3Roelofs A J,Thompson K, Ebetino FH, et al. Bisphospho- nates:molecular mechanisms of action and effects on bone cells,monocytes and macrophages[J]. Cur Pharm Des, 2010, 16 (27) : 2950-2960.
  • 4Komarova SV, Alexey P, Shum JW, et al. Convergent sig- naling by acidosis and receptor activator of NF-kappaB ligand (RANKL)on the calcium/calcineurin/NFAT path- way in osteoclasts [J]. Proc Nat Acad Sci USA,2005,102 (7) : 2643-2648.
  • 5林珏杉,董伟,张鹏,李鹏,孙红,戚孟春.唑来膦酸抑制破骨细胞分化中TRPV5、NFATc1的表达[J].南方医科大学学报,2014,34(9):1254-1258. 被引量:8
  • 6李鹏,林珏杉,张鹏,董伟,李金源,戚孟春.唑来膦酸对破骨细胞分化中钙调蛋白和钙调蛋白依赖性激酶Ⅱ基因表达的影响[J].中华口腔医学杂志,2013,48(11):694-698. 被引量:11
  • 7Reszka AA, Halasy-Nagy JM, Masarachia PJ,et al. Bis- phosphonates act directly on the osteoclast to induce caspase cleavage of Mstl kinase during apoptosis [J]. J Biol Chem, 1999,274: 34967-34973.
  • 8Dunford JE,Rogers MJ,Ebetino FH,et al. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac,Cdc42,and Rho GTPases [J]. J Bone Miner Res, 2006,21 (5) : 684-694.
  • 9Seales EC,Micoli KJ,McDonald JM. Calmodulin is a criti- cal regulator of osteoclastic differentiation, function,and survival[ J ]. J Cell Biochem, 2006,97 ( 1 ) : 45-55.
  • 10Zhang L,McKenna MA,Said-Al-Naief N,et al. Osteoclas- togenesis:the role of calcium and calmodulin[J]. Crit Rev Eukaryot Gene Expr, 2005,15( 1 ) : 1-13.

二级参考文献55

  • 1戚孟春,胡静,邹淑娟,韩力赤,罗恩.大鼠骨髓间充质干细胞和颅骨成骨细胞在张应力下细胞骨架的改变[J].华西口腔医学杂志,2005,23(2):110-112. 被引量:24
  • 2Edwards J R, Weivoda M M. Osteoclasts: malefactors of disease and targets for treatment[J]. Discov Med, 2012, 13(70) : 201 -210.
  • 3Teitelbaum S L. The osteoclast and its unique cytoskeleton [ J ]. Ann N Y Acad Sci, 2011, 1240:14 - 17.
  • 4Zou W, Kitanra H, Reeve J, et al. Syk, c-Src, the alphavbeta3 inte- grin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption[ J]. J Cell. Bid, 2007, 176(6) : 877 -888.
  • 5Reeve J L, Zou W, Liu Y, et al. SLP-76 couples Syk to the osteoclast cytoskeleton[ J]. J Immunol, 2009, 183(3) : 1804 - 1812.
  • 6Piper P K, Gruntmanis U. Management of osteoporosis in the aging male: focus on zoledronic acid [ J]. Clin Interv Aging, 2009, 4: 289 - 303.
  • 7Hasegawa H, Kido S, Tomomura M, et al. Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATcl activity[J]. J Biol Chem, 2010, 285(33) : 25448 -25457.
  • 8Mocsal A, Humphrey M B, Van-Ziffie J A, et al. The immunomodula- tory adapter proteins DAP12 and Fc receptor gamma-chain ( FcRgam- ma) regulate development of functional osteoclasts through the Syk tyro- sine kinase[ J]. Proc Nail Acad Sci U S A, 2004, 101(16) : 6158 - 6163.
  • 9Weinstein R S, Roberson P K, Manolagas S C. Giant osteoclast forma- tion and long-term oral bisphosphonate therapy [ J ]. N Engl J Med, 2009, 360(1): 53-62.
  • 10Negishi-Koga T, Takayanagi H. Ca2 : -NFATcl signaling is an essen- tial axis of osteoclast differentiation [ J ]. Immunol Rev, 2009, 231 (1) : 241 -256.

共引文献19

同被引文献57

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部